Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.14B | $2.22B | -3.31% |
Cost of Revenue | $1.42B | $1.37B | +3.86% |
Gross Profit | $724.9M | $851M | -14.82% |
Operating Income | $410.3M | $515.1M | -20.35% |
Net Income | $362.6M | $456.4M | -20.55% |
EPS (Basic) | $4.96 | $6.13 | -19.09% |
EPS (Diluted) | $4.91 | $6.05 | -18.84% |
R&D Expense | $50.6M | $50M | +1.20% |
SG&A Expense | $253.2M | $263.4M | -3.87% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.68B | $3.75B | -2.12% |
Current Assets | $1.55B | $1.97B | -21.38% |
Total Liabilities | $923M | $886.5M | +4.12% |
Current Liabilities | $516.5M | $533.5M | -3.19% |
Stockholders' Equity | $2.75B | $2.87B | -4.05% |
Cash & Equivalents | $490.9M | $898.6M | -45.37% |
Long-Term Debt | $202.6M | $207.3M | -2.27% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $463.3M | $537.4M | -13.79% |
Investing Cash Flow | $-273.9M | $-259.9M | -5.39% |
Financing Cash Flow | $-553.7M | $-270.1M | -105.00% |
Share Buybacks | $506.5M | $261.3M | +93.84% |
D&A | $114.7M | — | — |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 33.8% | 38.4% | -4.57% |
Operating Margin | 19.1% | 23.2% | -4.09% |
Net Margin | 16.9% | — | — |
ROE | 13.2% | — | — |
ROA | 9.9% | — | — |
Current Ratio | $3.002 | — | — |
Debt to Equity | $0.335 | — | — |
Other companies in Life Sciences Tools & Services